A carregar...
Effects of fluvastatin, an HMG‐CoA reductase inhibitor, on serum levels of interleukin‐18 and matrix metalloproteinase‐9 in patients with hypercholesterolemia
Background: Interleukin‐18 (IL‐18), a novel proinflammatory marker, and matrix metalloproteinaolemia. Hypothesis: The study was designed to investigate the influence of statin therapy in circulating IL‐18, MMP‐9, and endothelial function. Methods: We investigated the effects of a 12‐week therapy wit...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654498/ https://ncbi.nlm.nih.gov/pubmed/16250265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960280907 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|